Dasatinib Drugs Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


Dasatinib drugs are pharmacological substances used for treating various types of cancers such as chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The drugs inhibit BCR-ABL tyrosine kinase which promotes the development of leukemias. With increasing incidences of cancers worldwide, dasatinib drugs are highly demanded for therapeutic purposes. 

The global dasatinib drugs market is estimated to be valued at US$ 1350.6 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. 

Market key trends:

The expanded applications of dasatinib drugs have accelerated the market growth over the last few years. Besides treating CML and Ph+ ALL, dasatinib drugs are also being studied for their efficacy in other cancer types such as prostate cancer, ovarian cancer, non-small cell lung cancer and multiple myeloma. Ongoing clinical trials evaluating dasatinib drugs either as monotherapy or in combination with other drugs are providing positive results, which is expected to boost the adoption of dasatinib drugs to treat wider range of cancers in the forecast period. Furthermore, the increasing collaborations between drug manufacturers and research institutes for developing improved formulations of dasatinib drugs will also contribute to the market expansion.

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/dasatinib-drugs-market-5963

Segment Analysis

The dasatinib drugs market is dominated by the chronic myeloid leukemia (CML) sub-segment. Dasatinib is the recommended first-line treatment for newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP), according to National Comprehensive Cancer Network guidelines. This indication accounts for a large portion of dasatinib drug usage. The increasing prevalence of CML is fueling sales within this application segment. 

Key Takeaways

The global Dasatinib Drugs Market is expected to witness high growth during the forecast period of 2023 to 2030.

Regional analysis: North America has been the largest market for dasatinib drugs historically. This is attributed to the high prevalence of CML and presence of advanced healthcare facilities. Asia Pacific region is expected to grow at the fastest rate owing to rising healthcare expenditure and increasing awareness about CML treatment options in key emerging countries like India and China. 

Key players: Key players operating in the Dasatinib Drugs market are Bristol-Myers Squibb Company, MSN Labs, Lupin, Dr. Reddy’s Laboratories, Gilead Sciences, Inc., Hetero Labs, MANUS AKTTEVA BIOPHARMA LLP, Alembic Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., and Zhejiang Hisun Pharma. Bristol-Myers Squibb Company's Sprycel (dasatinib) is a leading brand in the market for treatment of CML. Generic versions of dasatinib from other key players are also gaining market share.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

The Where and the How: Unraveling Biology's Spatial Enigma with Omics

-
Image
In the fast-evolving landscape of biomedical research, a revolutionary technique has emerged that promises to unlock new dimensions of understanding within cellular landscapes – Spatial Omics. This cutting-edge approach combines the power of genomics, transcriptomics, proteomics, and more, with spatial information, creating a holistic view of biological systems. At its core, Spatial Omics involves mapping the molecular composition of tissues with spatial context. Traditional omics techniques provide valuable insights into the molecules present in a sample, but they lack the crucial information about where these molecules are located within the tissue. Spatial Omics bridges this gap by preserving the spatial architecture, offering unprecedented insights into cellular interactions, organization, and function. Read More @   https://www.digitaljournal.com/pr/news/coherent-market-insights/spatial-omics-market-revenue-growth-rate-customer-needs-trend-manufacturers-and-forecast-to-2030-10...
Read more

Fertility And Pregnancy Rapid Test Kits Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-
Image
The global Fertility And Pregnancy Rapid Test Kits Market is estimated to be valued at US$ 1,451.9 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Market Overview:  Pregnancy Rapid Test kits help in early detection of pregnancy in women. They are easy-to-usekits providing quick results within 5-10 minutes without laboratory or medical assistance.  Market key trends:  One of the key trends driving growth in the fertility and pregnancy rapid test kits market is increasing demand for home use pregnancy and ovulation prediction test kits. Manufacturers are focusing on making test kits more affordable and convenient for home use without medical supervision. Portable personal fertility monitors that track various fertility signs like cervical mucus, basal body temperature, etc on a mobile app are gaining popularity. The increasing use of digital technology in ...
Read more